Subscriber Authentication Point
lvrea
Home All issues Volume 25 / No 4 (Juillet 2016) Réanimation, 25 4 (2016) 408-418 References
Free Access
Issue
Réanimation
Volume 25, Number 4, Juillet 2016
Médecine interne et transversalité
Page(s) 408 - 418
Section Mise au Point / Update
DOI https://doi.org/10.1007/s13546-016-1211-6
Published online 15 June 2016
  • Bureau C, Pagan JCG, Layrargues GP, et al (2007) Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int 27:742–7 [CrossRef] [PubMed] [Google Scholar]
  • Rössle M (2013) TIPS: 25 years later. J Hepatol 59:1081–93 [CrossRef] [PubMed] [Google Scholar]
  • Bureau C, García-Pagán JC, Otal P, et al (2004) Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 126:469–75 [CrossRef] [PubMed] [Google Scholar]
  • Yang Z, Han G, Wu Q, et al (2010) Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents vs bare stents: a meta-analysis. J Gastroenterol Hepatol 25:1718–25 [CrossRef] [PubMed] [Google Scholar]
  • Luca A, Miraglia R, Caruso S, et al (2011) Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut 60:846–52 [CrossRef] [PubMed] [Google Scholar]
  • Perarnau JM, Le Gouge A, Nicolas C, et al (2014) Covered vs uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial. J Hepatol 60:962–8 [CrossRef] [PubMed] [Google Scholar]
  • Riggio O, Ridola L, Angeloni S, et al (2010) Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial. J Hepatol 53:267–72 [CrossRef] [PubMed] [Google Scholar]
  • Xiao T, Chen L, Chen W, et al (2011) Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone vs TIPS combined with embolotherapy in advanced cirrhosis: a retrospective study. J Clin Gastroenterol 45:643–50 [CrossRef] [PubMed] [Google Scholar]
  • Tesdal IK, Filser T, Weiss C, et al (2005) Transjugular intrahepatic portosystemic shunts: adjunctive embolotherapy of gastroesophageal collateral vessels in the prevention of variceal rebleeding. Radiology 236:360–7 [CrossRef] [PubMed] [Google Scholar]
  • Shi Y, Tian X, Hu J, et al (2014) Efficacy of transjugular intrahepatic portosystemic shunt with adjunctive embolotherapy with cyanoacrylate for esophageal variceal bleeding. Dig Dis Sci 59:2325–32 [CrossRef] [PubMed] [Google Scholar]
  • Chen S, Li X, Wei B, et al (2013) Recurrent variceal bleeding and shunt patency: prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization. Radiology 268:900–6 [CrossRef] [PubMed] [Google Scholar]
  • Fidelman N, Kwan SW, LaBerge JM, et al (2012) The transjugular intrahepatic portosystemic shunt: an update. AJR Am J Roentgenol 199:746–55 [CrossRef] [PubMed] [Google Scholar]
  • Bouza E, Muñoz P, Rodríguez C, et al (2004) Endotipsitis: an emerging prosthetic-related infection in patients with portal hypertension. Diagn Microbiol Infect Dis 49:77–82 [CrossRef] [Google Scholar]
  • Deibert P, Schwarz S, Olschewski M, et al (1998) Risk factors and prevention of early infection after implantation or revision of transjugular intrahepatic portosystemic shunts: results of a randomized study. Dig Dis Sci 43:1708–13 [CrossRef] [PubMed] [Google Scholar]
  • Gulberg V, Deibert P, Ochs A, et al (1999) Prevention of infectious complications after transjugular intrahepatic portosystemic shunt in cirrhotic patients with a single dose of ceftriaxone. Hepatogastroenterology 46:1126–30 [PubMed] [Google Scholar]
  • Sutcliffe JA, Briggs JH, Little MW, et al (2015) Antibiotics in interventional radiology. Clin Radiol 70:223–34 [CrossRef] [PubMed] [Google Scholar]
  • Rössle M, Euringer W (2012) Hepatic encephalopathy in patients with transjugular intrahepatic portosystemic shunt (TIPS). Clin Gastroenterol 211–20 [Google Scholar]
  • Jalan R, Elton RA, Redhead DN, et al (1995) Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol 23:123–8 [CrossRef] [PubMed] [Google Scholar]
  • Somberg KA, Riegler JL, LaBerge JM, et al (1995) Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors. Am J Gastroenterol 90:549–55 [PubMed] [Google Scholar]
  • Sanyal AJ, Freedman AM, Shiffman ML, et al (1994) Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 20:46–55 [PubMed] [Google Scholar]
  • Malinchoc M, Kamath PS, Gordon FD, et al (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31:864–71 [CrossRef] [PubMed] [Google Scholar]
  • Bureau C, Métivier S, D’Amico M, et al (2011) Serum bilirubin and platelet count: a simple predictive model for survival in patients with refractory ascites treated by TIPS. J Hepatol 54:901–7 [CrossRef] [PubMed] [Google Scholar]
  • Rabie RN, Cazzaniga M, Salerno F, et al (2009) The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt. Am J Gastroenterol 104:2458–66 [CrossRef] [PubMed] [Google Scholar]
  • Cazzaniga M, Salerno F, Pagnozzi G, et al (2007) Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt. Gut 56:869–75 [CrossRef] [PubMed] [Google Scholar]
  • Albillos A, Bañares R, González M, et al (2005) A meta-analysis of transjugular intrahepatic portosystemic shunt vs paracentesis for refractory ascites. J Hepatol 43:990–6 [CrossRef] [PubMed] [Google Scholar]
  • García-Pagán JC, Caca K, Bureau C, et al (2010) Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 362:2370–9 [CrossRef] [PubMed] [Google Scholar]
  • Salerno F, Cammà C, Enea M, et al (2007) Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Gastroenterology 133:825–34 [CrossRef] [PubMed] [Google Scholar]
  • Moitinho E, Escorsell A, Bandi JC, et al (1999) Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 117:626–31 [CrossRef] [PubMed] [Google Scholar]
  • Bañares R, Casado M, Rodríguez-Láiz JM, et al (1998) Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding. Am J Gastroenterol 93:75–9 [CrossRef] [PubMed] [Google Scholar]
  • Chau TN, Patch D, Chan YW, et al (1998) « Salvage » transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 114:981–7 [CrossRef] [PubMed] [Google Scholar]
  • Azoulay D, Castaing D, Majno P, et al (2001) Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol 35:590–7 [CrossRef] [PubMed] [Google Scholar]
  • De Franchis R (2015) Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol 63:743–52 [CrossRef] [PubMed] [Google Scholar]
  • Holster IL, Tjwa ETTL, Moelker A, et al (2016) Covered transjugular intrahepatic portosystemic shunt vs endoscopic therapy + β-blocker for prevention of variceal rebleeding. Hepatology 63:581–9 [CrossRef] [PubMed] [Google Scholar]
  • Sauerbruch T, Mengel M, Dollinger M, et al (2015) Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents vs hemodynamically controlled medical therapy. Gastroenterology 149:660–8 [CrossRef] [PubMed] [Google Scholar]
  • Monescillo A, Martínez-Lagares F, Ruiz-del-Arbol L, et al (2004) Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 40:793–801 [CrossRef] [PubMed] [Google Scholar]
  • Barange K, Péron JM, Imani K, et al (1999) Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. Hepatology 30:1139–43 [CrossRef] [PubMed] [Google Scholar]
  • Mahadeva S, Bellamy MC, Kessel D, et al (2003) Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections vs transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding. Am J Gastroenterol 98:2688–93 [CrossRef] [PubMed] [Google Scholar]
  • Lo GH (2014) Controlled trial of TIPS vs cyanoacrylate glue for gastric variceal bleeding. Gastrointest Endosc 79:182 [PubMed] [Google Scholar]
  • Mezawa S, Homma H, Ohta H, et al (2001) Effect of transjugular intrahepatic portosystemic shunt formation on portal hypertensive gastropathy and gastric circulation. Am J Gastroenterol 96:1155–9 [CrossRef] [PubMed] [Google Scholar]
  • Spahr L, Villeneuve JP, Dufresne MP, et al (1999) Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut 44:739–42 [CrossRef] [PubMed] [Google Scholar]
  • Rössle M, Gerbes AL (2010) TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update. Gut 59:988–1000 [CrossRef] [PubMed] [Google Scholar]
  • Dhanasekaran R, West JK, Gonzales PC, et al (2010) Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis. Am J Gastroenterol 105:635–41 [CrossRef] [PubMed] [Google Scholar]
  • Siegerstetter V, Deibert P, Ochs A, et al (2001) Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol 13:529–34 [CrossRef] [PubMed] [Google Scholar]
  • Michl P, Gülberg V, Bilzer M, et al (2000) Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites: effects in patients with organic or functional renal failure. Scand J Gastroenterol 35:654–8 [CrossRef] [PubMed] [Google Scholar]
  • Wong F, Pantea L, Sniderman K (2004) Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology 40:55–64 [CrossRef] [PubMed] [Google Scholar]
  • Brensing KA, Textor J, Perz J, et al (2000) Long-term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 47:288–95 [CrossRef] [PubMed] [Google Scholar]
  • Nair S, Verma S, Thuluvath PJ (2002) Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 35:1179–85 [CrossRef] [PubMed] [Google Scholar]
  • Guerrini GP, Pleguezuelo M, Maimone S, et al (2009) Impact of tips preliver transplantation for the outcome posttransplantation. Am J Transplant 9:192–200 [CrossRef] [PubMed] [Google Scholar]
  • Testino G, Leone S, Ferro C, et al (2012) Severe acute alcoholic hepatitis and hepatorenal syndrome: role of transjugular intrahepatic portosystemic stent shunt. J Med Life 5:203–5 [PubMed] [Google Scholar]
  • García-Pagán JC, Heydtmann M, Raffa S, et al (2008) TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology 135:808–15 [CrossRef] [PubMed] [Google Scholar]
  • Bhangui P, Laurent A, Amathieu R, et al (2012) Assessment of risk for non-hepatic surgery in cirrhotic patients. J Hepatol 57:874–84 [CrossRef] [PubMed] [Google Scholar]
  • Teh SH, Nagorney DM, Stevens SR, et al (2007) Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 132:1261–9 [CrossRef] [PubMed] [Google Scholar]
  • Azoulay D, Buabse F, Damiano I, et al (2001) Neoadjuvant transjugular intrahepatic portosystemic shunt: a solution for extrahepatic abdominal operation in cirrhotic patients with severe portal hypertension. J Am Coll Surg 193:46–51 [CrossRef] [PubMed] [Google Scholar]
  • Menahem B, Lubrano J, Desjouis A, et al (2015) Transjugular intrahepatic portosystemic shunt placement increases feasability of colorectal surgery in cirrhotic patients with severe portal hypertension. Dig Liv Dis 47:81–4 [CrossRef] [Google Scholar]
  • Vinet E, Perreault P, Bouchard L, et al (2006) Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: a retrospective, comparative study. Can J Gastroenterol 20:401–4 [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.